FDATue Nov 11, 2025
In the five trading days before SGHT's news on Nov 11 (Results: OMNI Device), traders made no large options trades, so the lean toward a fall comes only from new open contracts and option prices. Foreshadow rates that about normal: 18 out of 100. Options were pricing in a move of about 22.2%. The stock rose 8.0%, against the bets, so they were wrong.
That betting was busier than 65% of 587 finished FDA cases.
The line is the stock price. Under it is each measurement that goes into the score. The yellow days are the five that count; the faded ones show what's normal for this stock. The number at the right of each row is how many of the 100 points it added.
Watch the betting build up, one trading day at a time.
Hover over a day to see its numbers, or select the chart and use the arrow keys.
No large options trades were flagged in these five days.
Each measurement is compared with this stock's normal 60 days. The further above normal, the more points it earns, up to its maximum. The points add up to the score. For the formula, see How it works.
How much was bet
$0/day vs $0 normally, 0 vs 0 alerts/day, 0% sweeps
+0.0 of 25
How one-sided the bets were
net ask-side +$0/day vs +$0, calls $0, puts $0
+0.0 of 20
New contracts opened
12 contracts/day vs 24, calls +34, puts +0
+0.2
Of 25 finished FDA cases that scored 10 to 26 with bets leaning toward a fall, the bets were right in 3 (12%), and the stock at least moved the way they leaned in 14 (56%).
Options volume vs. normal
52th percentile on average, peak 98, baseline 36
+7.8 of 15
Change in the cost of protection
put−call IV -28.4 → 160.2 pts, typical 5-day move ±29.3
+10.0 of 10
Big off-exchange stock trades
$0/day in prints ≥ $1M vs $0, 0 prints
+0.0 of 10
Built from seven kinds of Unusual Whales data for SGHT: large options trades (flow alerts), new open interest, options volume, the put and call price gap (skew), dark-pool prints, daily prices and the expected move. What each one measures
Short answers from this case's data and Unusual Whales, written by Claude.